A new fluorescence PCR test can detect macrolide-resistant Mycoplasma pneumoniae strains in hours, targeting a key gap in pediatric respiratory care where treatment decisions often hinge on resistance patterns. A separate surveillance-focused item reported that Gram-negative infections in Jordanian ICUs show high levels of carbapenem resistance, reinforcing the urgency of local antimicrobial stewardship and rapid diagnostic adoption. Together, the updates underscore that resistance control increasingly depends on speed and local epidemiology—so clinicians can match therapy to the resistant pathogen landscape in real time.